The assistant routes by audience first. Patients receive programme information only. Prescribers and pharmacies access product-level information after MCAP verification. No therapeutic claims, no direct-to-public advertising of prescription-only medicines.
Routes patients to MCAP eligibility under MDR 2017, advises consultant referral, never makes therapeutic claims. Suggests next-step questions for the prescribing clinician.
HCP-verified flow. Returns interaction look-up against current Bedrocan formulary, current batch availability, and Certificate of Analysis on request. ASAI permits HCP-targeted communication.
Section 56 dispensing pharmacies access live stock status, order lead times, cold-chain requirements, and CDR/3 documentation. Direct line to compliance and supply teams.